Viela Bio enrolling kidney transplant recipients for phase IIa trial of VIB-4920 and belatacept Oct. 15, 2019
Prokarium receives funding from Wellcome for clinical development of lead vaccine program Oct. 10, 2019
FDA approves Rituxan for pediatric granulomatosis with polyangiitis and microscopic polyangiitis Sep. 30, 2019
RSS